EPB023 Global availability of skin biopsy for the diagnosis of Kaposi sarcoma in HIV treatment settingsE-posterDiagnostics of co-infections and co-morbidities
EPB024 Evaluation of a rapid multiplex assay based digital screening strategy in Canada: what's the verdict?E-posterDiagnostics of co-infections and co-morbidities
EPB025 Syndemics in people newly diagnosed with HIV in Manitoba, Canada. Importance of coinfections and comorbiditiesE-posterDiagnostics of co-infections and co-morbidities
EPB026 Low utilization of TB-LAM for TB screening among children under five with advanced HIV disease in Uganda: a descriptive analysis of surveillance dataE-posterDiagnostics of co-infections and co-morbidities
EPB027 Diagnostic performance of HbA1c, fasting blood glucose, and the oral glucose tolerance test among people with HIVE-posterDiagnostics of co-infections and co-morbidities
EPB028 Health related quality of life is impaired in people living with HIV and hepatic steatosisE-posterDiagnostics of co-infections and co-morbidities
EPB029 Improved tuberculosis case finding among patients with Advanced HIV Disease in Nigeria through the deployment of a point of care tuberculosis diagnostic testE-posterDiagnostics of co-infections and co-morbidities
EPB030 Adopting a Continuous Quality Improvement (CQI) platform as a real-time performance tracker for improving HIV care and treatment outcomes in BotswanaE-posterBiomarkers for the prediction of morbidity and mortality
EPB031 Soluble CD27 predicts progression of kidney dysfunction in people living with HIVE-posterBiomarkers for the prediction of morbidity and mortality
EPB032 Integrating 3HP-based tuberculosis preventive treatment (TPT) into Zimbabwe's fast track HIV model: aligning TPT and HIV visits, multi-month dispensing, and telephone follow-up were feasible and acceptableE-posterTuberculosis: Prevention, diagnosis, treatment
111 - 120 of 2485 items